Follow
Max Liebau
Max Liebau
University Hospital of Cologne, Germany
Verified email at uk-koeln.de
Title
Cited by
Cited by
Year
Exome capture reveals ZNF423 and CEP164 mutations, linking renal ciliopathies to DNA damage response signaling
M Chaki, R Airik, AK Ghosh, RH Giles, R Chen, GG Slaats, H Wang, ...
Cell 150 (3), 533-548, 2012
4132012
PDZD7 is a modifier of retinal disease and a contributor to digenic Usher syndrome
I Ebermann, JB Phillips, MC Liebau, RK Koenekoop, B Schermer, I Lopez, ...
The Journal of clinical investigation 120 (6), 1812-1823, 2010
2522010
Mutations in KIF7 link Joubert syndrome with Sonic Hedgehog signaling and microtubule dynamics
C Dafinger, MC Liebau, SM Elsayed, Y Hellenbroich, E Boltshauser, ...
The Journal of clinical investigation 121 (7), 2662-2667, 2011
2142011
Consensus expert recommendations for the diagnosis and management of autosomal recessive polycystic kidney disease: report of an international conference
LM Guay-Woodford, JJ Bissler, MC Braun, D Bockenhauer, ...
The Journal of pediatrics 165 (3), 611-617, 2014
1742014
Functional expression of the renin-angiotensin system in human podocytes
MC Liebau, D Lang, J Bohm, N Endlich, MJ Bek, I Witherden, ...
American Journal of Physiology-Renal Physiology 290 (3), F710-F719, 2006
1742006
NPHP4, a cilia-associated protein, negatively regulates the Hippo pathway
S Habbig, MP Bartram, RU Müller, R Schwarz, N Andriopoulos, S Chen, ...
Journal of Cell Biology 193 (4), 633-642, 2011
1732011
Dysregulated autophagy contributes to podocyte damage in Fabry’s disease
MC Liebau, F Braun, K Höpker, C Weitbrecht, V Bartels, RU Müller, ...
PloS one 8 (5), e63506, 2013
1372013
International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people
C Gimpel, C Bergmann, D Bockenhauer, L Breysem, ...
Nature Reviews Nephrology 15 (11), 713-726, 2019
1202019
A molecular mechanism explaining albuminuria in kidney disease
L Butt, D Unnersjö-Jess, M Höhne, A Edwards, J Binz-Lotter, D Reilly, ...
Nature metabolism 2 (5), 461-474, 2020
1122020
A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in …
O Gross, B Tönshoff, LT Weber, L Pape, K Latta, H Fehrenbach, ...
Kidney international 97 (6), 1275-1286, 2020
1082020
Imaging of kidney cysts and cystic kidney diseases in children: an international working group consensus statement
C Gimpel, EF Avni, L Breysem, K Burgmaier, A Caroli, M Cetiner, ...
Radiology 290 (3), 769-782, 2019
862019
AATF/Che‐1 acts as a phosphorylation‐dependent molecular modulator to repress p53‐driven apoptosis
K Höpker, H Hagmann, S Khurshid, S Chen, P Hasskamp, ...
The EMBO journal 31 (20), 3961-3975, 2012
852012
Perinatal diagnosis, management, and follow-up of cystic renal diseases: a clinical practice recommendation with systematic literature reviews
C Gimpel, FE Avni, C Bergmann, M Cetiner, S Habbig, D Haffner, J König, ...
JAMA pediatrics 172 (1), 74-86, 2018
752018
The ciliary protein nephrocystin-4 translocates the canonical Wnt regulator Jade-1 to the nucleus to negatively regulate β-catenin signaling
L Borgal, S Habbig, J Hatzold, MC Liebau, C Dafinger, I Sacarea, ...
Journal of Biological Chemistry 287 (30), 25370-25380, 2012
612012
Clinical courses and complications of young adults with autosomal recessive polycystic kidney disease (ARPKD)
K Burgmaier, S Kilian, B Bammens, T Benzing, H Billing, A Büscher, ...
Scientific Reports 9 (1), 7919, 2019
572019
Rationale, design and objectives of ARegPKD, a European ARPKD registry study
K Ebner, M Feldkoetter, G Ariceta, C Bergmann, R Buettner, A Doyon, ...
BMC nephrology 16, 1-7, 2015
572015
Low levels of urinary epidermal growth factor predict chronic kidney disease progression in children
K Azukaitis, W Ju, M Kirchner, V Nair, M Smith, Z Fang, ...
Kidney international 96 (1), 214-221, 2019
522019
The centrosomal kinase Plk1 localizes to the transition zone of primary cilia and induces phosphorylation of nephrocystin-1
T Seeger-Nukpezah, MC Liebau, K Höpker, T Lamkemeyer, T Benzing, ...
PLoS One 7 (6), e38838, 2012
502012
Mycophenolate mofetil therapy in children with idiopathic nephrotic syndrome: does therapeutic drug monitoring make a difference?
Á Hackl, O Cseprekál, M Gessner, MC Liebau, S Habbig, R Ehren, ...
Therapeutic Drug Monitoring 38 (2), 274-279, 2016
492016
Risk factors for early dialysis dependency in autosomal recessive polycystic kidney disease
K Burgmaier, K Kunzmann, G Ariceta, C Bergmann, AK Buescher, ...
The Journal of pediatrics 199, 22-28. e6, 2018
482018
The system can't perform the operation now. Try again later.
Articles 1–20